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The phytochemical curcumin has been showing a wide range of promising pharmacological 
properties, including anticancer action [1]. However, it is characterized by a low water solubility, 
rapid metabolism and elimination, limiting its biomedical use and therapeutic effect. The 
development and optimization of functionalized nanocarriers for curcumin aim to improve curcumin 
ADMET (absorption, distribution, metabolism, excretion and toxicology) and specificity for targeted 
therapies. In this work [2], stealth (aqueous and solid) magnetoliposomes containing calcium-
substituted magnesium ferrite nanoparticles, CaxMg1-xFe2O4 (with x = 0.25, 0.50, 0.75) were 
developed as nanocarriers for curcumin, following previously developed work [3]. Magnetic 
nanoparticles were synthesized by coprecipitation method and characterized on their colloidal stability 
and optical, magnetic and structural properties. Their superparamagnetic properties and crystalline 
structure, with sizes below 10 nm, make them suitable to act as magnetic mediators for 
magnetoliposomes guidance and hyperthermia action. The magnetoliposomes based on these 
nanoparticles have hydrodynamic diameters around or below 150 nm, a low polydispersity and the 
ability to encapsulate hydrophobic drugs, as the potential antitumor drug curcumin. Considering the 
leaky nature of tumor blood vessels, as a result of the presence of gaps within the range of 100 to 780 
nm between the endothelial cells of tumor capillaries and the lack of lymphatic drainage, the 
synthesized magnetoliposomes are an effective strategy for curcumin passive targeting. 
Magnetoliposomes were sterically stabilized with polyethylene glycol (PEG) to reduce in vivo 
opsonisation. The influence of an alternating magnetic field (AMF) on drug release over time (in 
PEGylated and non-PEGylated solid magnetoliposomes) was evaluated and compared with curcumin 
release by diffusion (Figure 1). The results suggest the potential of drug-loaded magnetoliposomes as 
nanocarriers that can be magnetically-guided to the tumor sites and act as agents for a synergistic 
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